Crescent Capital BDC: The Long Game of a Watchlist in a Tariff-Noisy Market
CCAP doubles down on patient rotation and deleveraging as NAV declines for an eighth straight quarter, while the market's focus shifts to tariffs and trade.
CCAP · Earnings Call · 2026-08-11
A Quiet Quarter in a Noisy Market
While the broader market fixates on tariff levels and trade resolutions, Crescent Capital BDC (CCAP) reported a quarter that was entirely internal and idiosyncratic. Net investment income of $0.36 beat the base dividend, but NAV fell again to $17.82, the eighth consecutive quarterly decline. Management's narrative is consistent: the legacy First Eagle portfolio is a known — and increasingly outsized — drag, and the cure is time, not expedience.This patience is the central tension. The stock has already shed 23% in the last 90 days and sits 49% below its 2021 peak. Yet management frames its approach as deliberate value-maximization, not stagnation. The keyword unrealized losses dominates the company's own trajectory, and the Q&A hammered on exactly that theme.Our experience has informed us that these workout situations rarely resolve within a single quarter and the most expedient realization is not necessarily the approach that maximizes value.
Rotation, Not Transaction
The watch list ticked up modestly to 15% of the portfolio, and the legacy First Eagle portfolio continues to be the primary source of stress. Henry Chung, President, reiterated that the longer-term rotation thesis was a factored diligence point at acquisition. The acquired portfolio has been reduced from over 70 positions to 27, now representing ~7% of CCAP's assets. Restructurings during the quarter crystallized $0.48 of realized losses, but these were offset by reversals of prior unrealized marks — a net zero impact on NAV. Separately, $0.47 of fresh unrealized losses came from ongoing operating pressure in a few challenged credits. This is not a new story. In the prior quarter, Jason Breaux, CEO, had already acknowledged the challenge: “We want to make sure that we're being conservative here.” — Jason Breaux, CEO or President · 2026-05-14 Henry had similarly noted, “we certainly do feel like we have a good handle in terms of where to keep our focus on today.” — Henry Chung, Portfolio Manager or similar investment role · 2026-05-14 The repeated message is that these workouts are multi-quarter by design. What is new — or at least sharper — is the explicit linkage of the fee structure and dividend framework to the deleveraging plan. Management has cut fees, implemented a revised dividend policy, and now pays a special dividend while simultaneously expecting portfolio realizations to bring leverage back within target range in the second half of 2026.Deleveraging with a Dividend
Gerhard Lombard, CFO, detailed the balance sheet actions: repaid $162 million of maturing fixed-rate debt, upsized the SPV facility to $500 million and the SMBC facility to $335 million, and funded the previously committed $50 million unsecured note. Leverage ended the quarter at 1.42x debt/equity, above the long-term target, but with $200 million of available borrowing capacity and $36 million cash. “We have visibility into several portfolio realizations in the near term, which all else equal, we expect will reduce leverage to within our target net leverage range during the second half of the year.” — Gerhard Lombard, CFO or Chief Financial Officer (inferred from discussing net investment income and financial details) · 2026-08-11 The market is not convinced. The dividend framework structured last quarter ties supplemental payouts to NAV lookback, and indeed no supplemental dividend was declared. The base dividend is $0.34, covered by NII, but the special dividends (a total of $0.09 across three quarters) add to the payout while NAV erodes. The fundamental data reinforces the tension: Operating income was -$22 million in the latest quarter, a 13% year-over-year improvement but still deep in the red. The company's net leverage is rising, and the effective net cash position is increasingly negative.Patience at a Price
The analyst questions — Robert Dodd pressing on the eight-quarter slide, Finian O'Shea on scale and M&A — reflect a market that wants a timeline. Jason's response is straightforward:But the execution is slow, and the stock is not waiting. The 90-day price trend is a steady -14%, with no sign of a bear-market rally. The market's own keyword stream is dominated by tariffs and trade negotiations — a topic CCAP does not mention in this quarter's call, underscoring that its problems are company-specific, not macro-beta. The distinction between the company's self-described “long-term” approach and the market's demand for near-term NAV stability is the heart of this report. Whether the patience is vindicated or the discount deepens further depends on whether the promised realizations arrive as quickly as management suggests. Until then, CCAP remains a test of whether a BDC can trade its way out of a legacy portfolio without losing its shareholders' patience first.We believe consistent execution is the best path to narrowing that valuation gap.